GLUD1 and metabolic disease: Metabolic diseases were observed in nine (6.2%) patients: three with citrullinemia, two with Leigh disease, one with ornithine transcarbamylase deficiency, one with pyridoxine dependent epilepsy, one with fumarase deficiency, and one with glutamate dehydrogenase 1 deficiency.